More younger people than before are expected to receive botulinum toxin and
hyaluronic acid in 2008, according to Millennium Research Group
WALTHAM, Mass., June 23 /PRNewswire/ -- Millennium Research Group (MRG) conducted a detailed survey focused on facial aesthetic procedures during the 2008 American Academy of Dermatology conference in San Antonio, Texas. Over 60 US-based dermatologists who frequently performed dermal filler and botulinum toxin procedures participated. Results of this study, found in MRG's US Dermatologist Survey: Facial Aesthetic Procedures and Product Trends 2008 report, concluded that dermatologists expect more young patients to undergo botulinum toxin and hyaluronic acid treatments in 2008 than in 2007.
Physicians expect that patients aged 26-35 age will represent more than 20% of total botulinum toxin patients in 2008, compared to a 2007 proportion of 6%. The 46-55 age range, and to a lesser extent the 36-45 demographic, are expected to represent a smaller proportion of total botulinum toxin patients as their younger counterparts increasingly obtain aesthetic injections.
"Facial aesthetic companies are increasingly positioning their products as preventive anti-aging measures," says Jaya Classen, Senior Analyst at MRG. "The idea is that if you use botulinum toxin earlier in life, you will prevent wrinkles rather than using the botulinum toxin when you already have the wrinkles."
Physicians are also expecting the proportion of hyaluronic acid patients in the 18-25 age group to rise over 2007. Although hyaluronic acid is traditionally used for wrinkle reduction, younger patients will increasingly undergo hyaluronic acid procedures for lip plumping and facial augmentation indications.
MRG's US Dermatologist Survey: Facial Aesthetic Procedures and Product
Trends 2008 report examines the industry's fastest-growing product
segments, including dermal filler and botulinum toxin products, as well as
|SOURCE Millennium Research Group|
Copyright©2008 PR Newswire.
All rights reserved